Here’s a summary of what I found about Greg Fenton of Zentek and his connections in the U.S.:
Key U.S. Connections & Roles - Altek Advanced Materials Inc. (Nevada, U.S.)
- Fenton resigned as CEO of Zentek (and director) to become full-time CEO of Altek Advanced Materials Inc., a private company incorporated in Nevada. Zentek Ltd.+2Investing.com+2
- He owns more than 50% beneficial equity interest in Altek. Zentek Ltd.+1
- Zentek has entered a non-arm’s length binding Letter of Intent (LOI) with Altek to license some of Zentek’s technologies (e.g. ZenGUARD™) for commercialization in the U.S. under this partnership. Altek would handle U.S. manufacturing/commercialization; Zentek retains the IP. Zentek Ltd.+2Investing.com+2
- Regulatory & Expansion Strategy via FTI Consulting (Washington, D.C.)
- Under his leadership at Zentek, Fenton initiated a partnership with FTI Consulting’s Government Affairs arm (based in Washington, D.C.) to support the company's U.S. expansion, especially helping navigate U.S. regulatory approval for its nanotechnologies (like ZenGUARD). Zentek Ltd.
- This indicates he’s dealing with U.S. federal regulatory frameworks (e.g. approvals, possibly EPA, FDA depending on the tech) and leveraging consulting/advisory services in the U.S. Zentek Ltd.
- Licensing & Commercialization Deals for U.S. Market
- The LOI with Altek includes royalties of 5-8% on net sales of ZenGUARD or ZenGUARD-based products sold in the U.S. under certain thresholds. Zentek Ltd.+1
- The initial licensing term is 5 years, with an option to renew for another 5 years. Zentek Ltd.
- Advisory/Board Relationships
- After stepping down as CEO, he will/has moved into an advisory role to Zentek’s Board. Zentek Ltd.
- Also, through Altek, there’s a “related-party” dimension between him as owner/CEO of Altek and Zentek’s licensing of its IP through Altek for U.S. commercialization. Zentek Ltd.
|
